Patents by Inventor Xiaoping Chen

Xiaoping Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240127186
    Abstract: An interaction method and apparatus and an electronic device. The method comprises: displaying a first application interface, wherein the first application interface comprises an interface of a first application; and creating a second application account in the first application interface, wherein the second application account is used for logging in a second application. Therefore, a new interaction mode is provided.
    Type: Application
    Filed: December 21, 2023
    Publication date: April 18, 2024
    Inventors: Xiaoping ZHANG, Yunsheng HAO, Jialu WANG, Yi WEI, Pengzhan XU, Guichao REN, Boyu ZHOU, Zitian GUO, Yuxiang LI, Jieli LIANG, Xiaofei GAO, Daozhi LIN, Hong ZOU, Wentao LIU, Zheng CHEN, Shanshan LING
  • Publication number: 20240108580
    Abstract: Disclosed are a decoquinate liposome, a preparation method therefor and a use thereof. The preparation raw materials for the decoquinate liposome comprise the following components in parts by weight: 1 part of decoquinate and 2-20 parts of lecithin. The liposome is stable, shows favorable malaria resistance effects in-vivo and in-vitro with respect to animal bodies, can be used for quickly relieving the conditions of malaria, particularly subtertian malaria, and is safe. The preparation method is simple and feasible, and has the potential for mass production.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 4, 2024
    Inventors: Sumei ZENG, Hongxing WANG, Xiaohui NING, Yinzhou FAN, Siting ZHAO, Li QIN, Xiaoping CHEN
  • Publication number: 20240097143
    Abstract: A battery unit includes an electrode assembly and a support component. The electrode assembly includes a positive electrode plate and a negative electrode plate that have opposite polarities, and a separator separating the positive electrode plate and the negative electrode plate. The electrode assembly is wound around an outer periphery of the support component. An outer peripheral wall surface of the support component includes a first arc surface and a second arc surface. A first end of the first arc surface is connected to a first end of the second arc surface, and a second end of the first arc surface is spaced apart from a second end of the second arc surface so as to form a step region on the outer peripheral wall surface. The step region is configured to accommodate at least part of the electrode assembly.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 21, 2024
    Inventors: Yulei FAN, Yiheng WANG, Xiaoming GE, Manman WANG, Yujie CHEN, Xiaoping ZHANG
  • Publication number: 20240040976
    Abstract: The invention relates to a planting method of DendrobiumnobileLindl, it comprises the following steps: Selecting betel palm trees that are more than 5 years old or or more than 6 meters high; Selecting the DendrobiumnobileLindl seedlings with a height of more than 12 cm, with 1 or 2 new buds and complete roots, stems and leaves, and dividing DendrobiumnobileLindl seedlings into 2-4 clumps a group; Combing and aligning the roots of each group of DendrobiumnobileLindlseedlings, taking one group of DendrobiumnobileLindl seedlings and sticking them to the knot of the betel plain tree each time, then using a cotton rope or a tie to wind and fix the DendrobiumnobileLindl seedlings on the betel palm tree trunk from the stems of each group of DendrobiumnobileLindl seedlings; Putting the roots below the stembase of the DendrobiumnobileLindlseedling on the betel palm tree trunk and smearingdendrobium nutrient.
    Type: Application
    Filed: December 27, 2021
    Publication date: February 8, 2024
    Inventors: Guiyang PENG, Wanxing ZHANG, Wu LI, Xiangming NING, Xiaoping CHEN, Haisong FU, Guobing WU, Wei DENG
  • Publication number: 20230312252
    Abstract: The application discloses a method for replacing seedbed culture substrate and a conveyor belt seedbed, the flatbed truck is used to receive the dropped culture substrate at the end of the conveyor belt that has been driven all the time, without manual removal by workers. The conveyor belt continues to drive until the flatbed truck is fully loaded or only when the culture substrate on the conveyor belt is emptied, only need to place the flatbed truck full of culture substrate at the head end of the conveyor belt when placing new culture substrate, and turn on the conveyor belt, which speeds up the efficiency of replacing the culture substrate, and this method only requires one person can complete the replacement of the culture substrate on the seedbed, which solves the technical problem that the existing method of replacing the culture substrate is to manually remove the culture substrate on the seedbed, which leads to the long time for replacing the culture substrate and low work efficiency.
    Type: Application
    Filed: December 27, 2021
    Publication date: October 5, 2023
    Inventors: Guiyang PENG, Wu LI, Xiangming NING, Wanxing ZHANG, Xiaoping CHEN, Haisong FU, Guobing WU, Wei DENG
  • Publication number: 20230255149
    Abstract: The invention relates to an electric seedling greenhouse, The illumination intensity in the seedling greenhouse is detected by the illumination transmitter, the light intensity information in the seedling greenhouse is transmitted to the information processing module, the light intensity preset value required by plants is set in the information processing module, the shading rate of the first sunshade device is not equal to the shading rate of the second sunshade device, when the light intensity is higher than the preset value, the light intensity collected by the illuminance transmitter is transmitted to the information processing module, and it is judged to meet the value of starting sunshade device, then analyze the light intensity to automatically select the corresponding shading rate of the sunshade device to open and complete the shading.
    Type: Application
    Filed: December 27, 2021
    Publication date: August 17, 2023
    Inventors: Guiyang PENG, Wu LI, Xiangming NING, Wanxing ZHANG, Xiaoping CHEN, Haisong FU, Guobing WU, Wei DENG
  • Publication number: 20230250035
    Abstract: A processing method of Dendrobium organic fertilizer, which comprises the following steps: Step 1: select 4-6 parts by weight of rotten animal dung; Step 2: add 0.5-1.5 parts by weight of disinfectant to animal dung; Step 3: add disinfectant to dung and let it stand for 1-3 hours; Step 4. uniformly mixing to obtain organic fertilizer. The invention controls the viscosity of animal dung within a range, thereby improving the adhesion between animal dung and Dendrobium, slowing down the drying and hardening speed of animal dung, moisturizing the roots, sterilizing animal dung and reducing the probability of affecting the growth of Dendrobium.
    Type: Application
    Filed: December 27, 2021
    Publication date: August 10, 2023
    Inventors: Guiyang PENG, Xiangming NING, Wu LI, Wanxing ZHANG, Xiaoping CHEN, Haisong FU, Guobing WU, Wei DENG
  • Publication number: 20230247951
    Abstract: This application provides a dendrobium watering method and system, by way of imitation of wild cultivation of dendrobium on volcano, first on the volcano cant selection from the top 15 to 25 cm line code position, use a hard masonry nail line code insert to spray rod fixed to the fixed position of the line of code. The ground lance G-shaped nozzle is higher than the top of the volcano.
    Type: Application
    Filed: December 27, 2021
    Publication date: August 10, 2023
    Inventors: Guiyang PENG, Wanxing ZHANG, Xiangming NING, Wu LI, Xiaoping CHEN, Haisong FU, Guobing WU, Wei DENG
  • Publication number: 20230203055
    Abstract: The present invention relates to a novel compound (formula I), which has cancer treatment activity. The present invention also relates to a preparation method for the compound and a pharmaceutical composition containing the compound.
    Type: Application
    Filed: April 27, 2021
    Publication date: June 29, 2023
    Inventors: Hao Wu, Xiaoping Chen, Jun Yu, Yuan Lu, Jiangqi He, Wei Wang, Bo Zhan, Boyan Li, Yunlai Zhang, Dong Wang, Xiujun Xie, Xiaoguan Zhu, Hong Lan, Jiabing Wang, Lieming Ding
  • Publication number: 20230167107
    Abstract: The present invention provides crystals of a quaternary ammonium salt structure compound, i.e., (2R,3R)-3-[(2-cyclopentyl-2-hydroxy-2-phenyl)ethoxy]-1-(3-phenoxypropyl) azabicyclo[2,2,2]octylonium bromide (Compound I). A Type-A crystal of Compound I displays diffraction peaks at the following diffraction angles 2? in a X-ray powder diffraction pattern thereof: 5.7±0.2 degrees, 12.9±0.2 degrees, 16.7±0.2 degrees, 18.0±0.2 degrees, 19.5±0.2 degrees, 21.1±0.2 degrees, 22.3±0.2 degrees and 23.3±0.2 degrees. A Type-B crystal of Compound I displays diffraction peaks at the following diffraction angles 2? in a X-ray powder diffraction pattern thereof: 5.2±0.2 degrees, 15.8±0.2 degrees, 16.9±0.2 degrees, 17.7±0.2 degrees, 19.5±0.2 degrees, 20.2±0.2 degrees and 22.1±0.2 degrees. The present application also relates to a new method for preparing Compound I and applications of the two novel crystals in the field of medicine.
    Type: Application
    Filed: April 24, 2021
    Publication date: June 1, 2023
    Applicant: BEIJING SHOWBY PHARMACEUTICAL CO., LTD.
    Inventors: Xiaoping CHEN, Zejun GAO
  • Publication number: 20230110635
    Abstract: A drug for preventing and/or treating a brain tumor and an application thereof. The drug comprises Plasmodium. The drug has significant preventive and/or therapeutic effects on a brain tumor, and is capable of inhibiting the growth of the brain tumor and prolonging the life span of a patient, and has no obvious side effects and has a high safety level. The drug expands treatment methods for brain tumors. Due to the specificity and sensitivity of brain tissues, chemotherapeutic drugs cannot easily cross the blood-brain barrier and exert anti-tumor effects. The drug mainly regulates the immunological functions and inflammation-related factors of the body to break through the blood-brain barrier by fully activating immunocompetence and inhibiting the growth of a brain tumor, thereby extending lifespan.
    Type: Application
    Filed: July 1, 2020
    Publication date: April 13, 2023
    Inventors: Zhu Tao, Wenting Ding, Zhipeng Cheng, Yinfang Feng, Li Qin, Xiaoping Chen
  • Patent number: 11602532
    Abstract: Hot-melt extrusion for producing solid solution comprising nanoparticle formulation of decoquinate is disclosed. Aqueous phase comprising the nanoparticles of hot-melt extruding products is homogeneous and stable. Provided is the composition comprising the solid solution of decoquinate and a method of hot-melt extrusion for producing this composition comprising the solid dispersion of decoquinate. Furthermore, provided is the solid solution comprising nanosized decoquinate formulation having improved water solubility and enhanced delivery of decoquinate in digestive system for absorption, increasing bioavailability, and the efficacy against malaria at the liver stage.
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: March 14, 2023
    Assignee: CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
    Inventors: Hongxing Wang, Shuanghong Liang, Yinzhou Fan, Zhenping Huang, Siting Zhao, Li Qin, Xiaoping Chen
  • Publication number: 20230062486
    Abstract: Provided are compounds of formula (I), which have KRAS mutation tumor regulating activity. Also provided are a method for providing these compounds and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: December 18, 2020
    Publication date: March 2, 2023
    Inventors: Hao Wu, Xiaoping Chen, Yuan Lu, Jun Yu, Xiujun Xie, Jiangqi He, Shuibiao Fu, Qi Shen, Letian Zhang, Xiaoguan Zhu, Hong Lan, Jiabing Wang, Lieming Ding
  • Patent number: 11524060
    Abstract: Disclosed are an attenuation system and the use thereof for attenuating plasmodia, specifically the use of an EF1g gene for attenuating plasmodia. The attenuation system regulates the expression or degradation of the EF1g gene by using a regulatory system, thereby controlling the growth of plasmodia and achieving the attenuation of plasmodia.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: December 13, 2022
    Assignee: GUANGZHOU CAS LAMVAC BIOTECH CO., LTD
    Inventors: Xingxiang Liang, Jianhua Su, Meiling Wang, Ying Tong, Yongchao Yao, Li Qin, Xiaoping Chen
  • Patent number: 11447485
    Abstract: The invention provides a class of compounds represented by formula (I), having bifunctional active quaternary ammonium salt structure of a ?2-adrenoreceptor agonist and an M receptor antagonist, a pharmaceutically acceptable salt, solvate, and optical isomer thereof. A pharmaceutical composition comprising such a compound with quaternary ammonium salt structure, a method for preparing such a compound with quaternary ammonium salt structure and an intermediate thereof, and uses thereof in treating pulmonary disorders are also provided. The compounds of the invention have high selectivity to the M receptor subtype, and have less adverse reaction and lower toxic and side effects in the treatment of pulmonary diseases such as COPD and asthma.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: September 20, 2022
    Assignee: Beijing Showby Pharmaceutical Co., Ltd.
    Inventors: Shouming Wen, Zejun Gao, Junyi Wang, Xiaoping Chen
  • Publication number: 20220249643
    Abstract: An anti-neoplastic combined pharmaceutical composition and application thereof. The combined pharmaceutical composition is prepared from plasmodia and chemotherapeutic drugs. The combined pharmaceutical composition combines chemotherapy with Plasmodium immunotherapy, has high biosafety, has stronger antineoplastic activity than single chemotherapy or single Plasmodium immunotherapy, can prolong the lifetime of cancer patients, and provides a new strategy and idea for cancer treatment. Moreover, the dosage of the chemotherapy drugs can be reduced, toxic and side effects caused by the chemotherapy drugs are reduced, and treatment costs of tumor patients are reduced. In addition, the combined pharmaceutical composition can promote release of a tumor antigen, induces a stronger anti-tumor specific immune response, and exerts the continuous synergistic effect of immunotherapy and chemotherapy.
    Type: Application
    Filed: June 29, 2020
    Publication date: August 11, 2022
    Inventors: Zhu Tao, Zhongkui Kang, Li Qin, Xiaoping Chen
  • Publication number: 20220214347
    Abstract: Disclosed are a combined formulation kit for analyzing the phenotype and function of a CD1c+ dendritic cell subset and the use thereof, wherein the detection objects of the kit include CD1c, CD40, IL-6 and IL-10. The kit can be used to efficiently and quickly identify the phenotype of a CD1c+ dendritic cell subset in peripheral blood and analyze the function thereof, thereby ensuring accuracy and reducing the economic cost produced by detecting a large number of surface antigen molecules, and the detection method is also simple to implement.
    Type: Application
    Filed: December 18, 2019
    Publication date: July 7, 2022
    Inventors: Fang Zhou, Xiaoping Chen, Li Qin, Yanli Gu, Wenlong Xu, Yong Lu, Xu Chang, Guojian Wei, Zhien Rong
  • Patent number: 11287055
    Abstract: The present invention discloses an executive system for driving a valve to open and close, comprising a first housing, a linkage block, a first drive rod and a drive mechanism. Wherein, the first housing has a first inner cavity; a medium channel is provided in a side wall of the first housing; an outer peripheral wall of the linkage block is arranged on a wall of the first inner cavity in a slidable and sealed manner, and the linkage block partitions the first inner cavity into an upper cavity and a lower cavity; the medium channel is communicated with the upper cavity; a bottom part of the first drive rod sequentially passes through a top part of the first housing and the linkage block and extends into the lower cavity; a position-limiting part on the bottom part of the first drive rod blocks the linkage block within a region between the position-limiting part and the top part of the first housing; the drive mechanism is provided on top of the first drive rod.
    Type: Grant
    Filed: December 25, 2018
    Date of Patent: March 29, 2022
    Inventors: Yueqiang Bao, Xiaoping Chen, Zhengwen Wang
  • Patent number: 11246836
    Abstract: Implants comprising an antimalarial agent such as decoquinate or another therapeutic drug are disclosed. The implants can be in the form of a complex comprising a drug, a lipid or lipids and optionally a polymer carrier. The present invention provides methods for preparing implants wherein the implants comprise decoquinate or another therapeutic drug, and a lipid or lipids such as cholesterol, monoglycerides, or diglycerides, and optionally a small percentage of a biocompatible polymer based on the total implant weight. The implants are useful for releasing a therapeutic drug at a constant level and maintaining a prophylactic or therapeutic level of the drug in a subject, for preventing a malarial infection or treating other diseases or disorders.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: February 15, 2022
    Assignee: BLUELIGHT PHARMATECH CO., LTD.
    Inventors: Hongxing Wang, Shuanghong Liang, Yinzhou Fan, Xiaoyi Huang, Li Qin, Xiaoping Chen
  • Patent number: 11148077
    Abstract: A composite filter cartridge, comprising a filter cartridge body provided with two filter devices. Each filter device is respectively provided with a support component which fixes the filter device, and the filter devices are arranged in a linear manner and fixed with respect to one another. Each filter device is respectively provided with an independent housing, a filter module and a filter water channel, the filter module and the filter water channel being arranged within the housing, the filter water channel sequentially comprising a water inlet cavity and a water outlet cavity, the water inlet cavity and the water outlet cavity being connected via the corresponding filter module.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: October 19, 2021
    Assignee: Foshan Viomi Electrical Technology Co., Ltd.
    Inventor: Xiaoping Chen